Healthcare

Halia Therapeutics Completes First-in-Human Phase 1 Study of HT-4253, a Novel LRRK2 Inhibitor Targeting Neuroinflammation

LEHI, Utah, June 16, 2025, 08:30 GMT-04

Halia

Read full article →

Innovative Molecules Completes Enrollment of Phase 1b Clinical Trial of IM-250

MUNICH, June 16, 2025, 07:39 GMT-04

Innovative-Molecules

Read full article →

Zentiva acquires heritage brands from Aboca to expand natural-based Consumer Healthcare solutions across Europe

PRAGUE, June 16, 2025, 04:00 GMT-04

Zentiva

Read full article →

Clarivate Identifies Radioligand Therapy Innovators as Companies to Watch in the Future of Precision Oncology

LONDON, June 16, 2025, 04:00 GMT-04

Clarivate-Oncology

Read full article →

Canadian hospital system leverages Sectra's AI service to enhance patient care and workflow efficiency

LINKÖPING, Sweden and MISSISSAUGA, ON, June 16, 2025, 02:54 GMT-04

SECTRA-AI-PatientCare

Read full article →

Leader Healthcare Implements SAP S/4HANA Public Cloud With Accely To Drive Operational Excellence

DUBAI, UAE, June 16, 2025, 02:43 GMT-04

ACCELY-LeaderHealthca

Read full article →

Innocan Pharma Highlights Breakthrough Narrative Review on Liposomal Synthetic CBD for Chronic Pain: A Novel Non-Opioid Analgesic Approach

HERZLIYA, Israel and CALGARY, AB, June 13, 2025, 16:00 GMT-04

Innocan-Liposomal-CBD

Read full article →

Diagnostic Electrocardiograph/ECG Market worth US$15.18 billion by 2032 with 7.4% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., June 13, 2025, 10:30 GMT-04

MARKETSANDMARKETS

Read full article →

IoT Medical Devices Market worth US$154.74 billion by 2030 with 18.9% CAGR | MarketsandMarkets™.

DELRAY BEACH, Fla., June 13, 2025, 10:01 GMT-04

MarketsandMarkets

Read full article →

Keymed Biosciences Announces the Latest Clinical Trial Results of CM336 Published in the New England Journal of Medicine

CHENGDU, China, June 13, 2025, 05:42 GMT-04

Keymed-Clinical-Trial

Read full article →

Illuccix® Prostate Cancer PSMA-PET Imaging Agent Approved in Greece

MELBOURNE, Australia, June 13, 2025, 04:35 GMT-04

Telix-Pharmaceuticals

Read full article →

BioArctic to initiate next cohorts in exidavnemab Phase 2a study after positive safety review

STOCKHOLM, June 13, 2025, 02:37 GMT-04

BIOARCTIC-Clinical

Read full article →

Merry Life Launches Global Phase II Trial of TML-6, The First Drug Targeted at Autolysosome pathway for Therapy of Alzheimer's Disease

TAINAN, June 13, 2025, 22:33 GMT-04

Merry-Life

Read full article →

4 Emerging Graft versus Host Disease Therapies That Could Change the Treatment Landscape | DelveInsight

LAS VEGAS, June 12, 2025, 17:46 GMT-04

DelveInsight-Business

Read full article →

Cancer Pain Market Set to Transform by 2034 Due to Launch of Breakthrough Therapies | DelveInsight

LAS VEGAS, June 12, 2025, 17:31 GMT-04

DelveInsight

Read full article →

Daewoong Pharmaceutical Launches NABOTA in Qatar, Expands Presence in High-Potential GCC Aesthetic Market

DOHA, Qatar, June 12, 2025, 15:21 GMT-04

Daewoong-Pharmaceutic

Read full article →

European Commission Grants Orphan Drug Designation to Florbetaben (18F) for Diagnosis of ATTR Amyloidosis

BERLIN, June 12, 2025, 11:50 GMT-04

Life-Molecular-EU

Read full article →

Lunit AI Used Again for Mass Screening During 2025 Hajj Season in Saudi Arabia

SEOUL, South Korea, June 12, 2025, 11:20 GMT-04

Lunit

Read full article →

After Major Oncology Conference, All Eyes Turn to Industry Innovation

VANCOUVER, BC, June 12, 2025, 09:02 GMT-04

USA-NEWS-GROUP

Read full article →

Reacta Healthcare announces transformation into a facility for multi-allergen manufacturing

DEESIDE, Wales, June 12, 2025, 07:06 GMT-04

Reacta-Healthcare

Read full article →